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1.

Introduction
Optimal management of urinary tract stones located in the proximal part of the ureter has been controversial for a long period of time, with the clinical introduction of minimally invasive treatment approaches making the decisionmaking process more complex than ever [1] [2] [3] . Bringing the patient(s) to a completely stone-free status with limited or no morbidity is the ultimate goal, and to achieve that, in addition to stone (size and location) and patientrelated factors (quality of life, length of hospital stay, and analgesic requirement), the surgeon's experience and the availability of particular technologies are the crucial factors that should be considered on an individual basis. Among the available management alternatives, currently both extracorporeal shock wave lithotripsy (SWL) and ureteroscopy (URS) are the most commonly applied procedures [4, 5] , with varying success and complication rates reported in the literature.
Because of its noninvasive and practical nature, SWL has been the preferred therapeutic option [6] [7] [8] , but its success depends on the location of the treated stone(s), with greater success in the management of proximal ureteral calculi. The success rates tend to decrease for distal stones, while stones treated in an emergency setting have a high success rate, similar to those treated with delayed lithotripsy [6] [7] [8] [9] [10] [11] [12] . However, the clinical introduction of URS has significantly changed the treatment concepts for ureteral stones. As a result of the accumulated experience and clinical use of thinner and/or flexible instruments, nowadays the vast majority of ureteral calculi can be treated with URS as well as SWL [3, 13, 14] .
The advantage of the endoscopic approach is the adequate and immediate decompression of the obstruction in one session with significantly higher stone-free rates when compared with SWL [3, 13, 14] . Concerning the complications, traditionally, ureteroscopic techniques have been associated with greater complication rates than SWL (9-11% vs 4%) [13] . However, the use of small-calibre, semirigid, and flexible ureteroscopes combined with holmium:ytrriumaluminium-garnet (Ho:YAG) laser disintegration have improved the stone-free rates and decreased the risk of severe complications.
The objective of this review was to determine the benefits and harms of URS compared with SWL in the treatment of upper ureteric stones in children and adults.
2.
Evidence acquisition 2.1.
Search strategy
We conducted a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement [15] and the Cochrane Handbook for Systematic Reviews of Interventions [16] . Medline, Embase, and Cochrane controlled trials databases and clinicaltrial.gov were searched between January 2000 and November 2014 for all relevant, English-language publications. This search was supplemented by manually searching the reference list of The European Association of Urology (EAU) Guidelines on Urolithiasis and by discussion with relevant trialists and organisations. The search strategy is published elsewhere [17] . Following deduplication, two review authors (N.G. and T.D.) independently screened the titles and abstracts of the identified records for eligibility. The full text or abstract from congress proceedings of all potentially eligible records were retrieved and scrutinised independently by two review authors using a standardised form, linking together multiple records of the same study. In the case of any incompletely reported data, study authors were contacted. Any disagreements were resolved by discussion or by consulting a third review author (S.D.).
Types of study design included
All randomised controlled trails (RCTs) and quasi-randomised controlled trials (QRCTS) comparing any subtype or variation of URS and SWL were included. Comparative nonrandomised studies (NRSs) were excluded, unless they had more than 10 patients per study arm. Noncomparative studies (eg, single-arm case series) were excluded. Only studies published from the year 2000 onwards were included to reduce the influence of general changes in medical procedures on the results. Furthermore, only English language studies, either published in peer-reviewed reported in 11 out of 22 studies. In eight studies, it was possible to report this as a Clavien-Dindo Grade. Higher complication rates across all grades were reported for URS compared with SWL. For intragroup (intra-SWL and intra-URS) comparative studies, 25 met the inclusion criteria. These studies varied greatly in outcomes measured with data being heterogeneous.
Conclusions: Compared with SWL, URS was associated with a significantly greater SFR up to 4 wk but the difference was not significant at 3 mo in the included studies. URS was associated with fewer retreatments and need for secondary procedures, but with a higher need for adjunctive procedures, greater complication rates, and longer hospital stay.
Patient summary: In this paper, the relative benefits and harms of the two most commonly offered treatment options for urinary stones located in the upper ureter were reviewed. We found that both treatments are safe and effective options that should be offered based on individual patient circumstances and preferences. # 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved. journals or abstracts, including those published in congress proceedings, were included.
Types of participants included
The population included in our search were male and female adults and children of any ethnicity with a single radio-opaque stone in the upper ureter (ie, defined as above sacro-iliac junction, or iliac vessel crossing, or as defined by trialists). Recurrent or first-time stone formers were eligible, regardless of whether or not they were symptomatic. Pelvic-ureteric junction stones and middle ureteric stones were also included. Patients with or without JJ-stent/ nephrostomy insertion before treatment were allowed, as were patients with a solitary kidney. All stone sizes and compositions were included. Studies containing populations with the following characteristics were excluded: pregnant women, previous open ureteral surgery (eg, ureteric reimplantation, ureterolithotomy), ureteric stricture, anatomical abnormalities (eg, duplex kidney, pelvic-ureteric junction obstruction, horseshoe kidney), transplanted kidney, simultaneous treatment of ipsilateral stone in kidney (however, if an incidental stone was present in kidney but not treated, this was allowed), two or more ipsilateral ureteric stones, patients who were anticoagulated or had a coagulopathy, radio-lucent stones, and lower ureteric stones.
Types of interventions included
For URS, the included interventions were: all subtypes and variations including semirigid URS, flexible URS, and with ureteroscope sizes ranging from 4.5-10 Ch; additional sessions (ie, >1) were considered as an outcome. For SWL, the included interventions were: all subtypes and variations including electrohydraulic, piezo-electric, and electro-magnetic. Two different definitions of the intervention were used: (1) first definition-only one SWL session was allowed, and any additional session was considered as a separate outcome (ie, retreatment); (2) second definition-two to three SWL sessions were allowed as preplanned intervention (ie, as a package of care).
Studies comparing any URS versus URS, or any URS versus SWL, or any SWL versus SWL were included. Analysis of intergroup comparisons (ie, SWL compared with URS) and intragroup comparisons (ie, SWL compared with variation of SWL or URS compared with variation of URS) were done separately.
Types of outcomes measures included
The primary benefit outcome was: stone-free rate (SFR). For URS, this was the immediate SFR after treatment. However, allowances were made for studies, which measured this outcome at 24 h rather than immediately. For SWL, the 1 mo stone-free status was measured according to the two definitions outlined above. Also, alternative time points for measuring SFR were allowed for up to 3 mo. This was done in order to find not only data in studies where one SWL session was the basis for measuring SFR, but also to find data in studies where multiple SWL sessions were considered as one package of care before SFR was measured. SFR was defined as no stone fragments remaining; if an alternative definition was used by the trialist (eg, fragments < 4 mm), data was included but this was recorded as residual stone fragments rather than stone free (ie, the reviewers had to recode the data). SFR could also, if defined as such by the trialist, be measured as the time taken to achieve stone-free status, that is, not rates but rather time to stone-free status.
Secondary outcomes were retreatment rate (ie, more than 1 URS or SWL session according to definitions of intervention), need for a secondary procedure (ie, a procedure to clear the stone beyond the primary procedure, including retreatment using the same modality-more than 1 URS or SWL session, or other modality, eg, percutaneous nephrolithotomy [PCNL]), need for an adjunctive procedure (ie, a procedure to deal with a postoperative complication or procedures incidental to the stone removal process, eg, nephrostomy or JJ stent insertion for obstruction). Mean length of hospital stay, pain outcomes (as defined by trialist, eg, analgesic requirements or pain scores), quality of life measures, patient satisfaction measures (as reported by the trialist), hospital readmission rates, and number of emergency department visits were also recorded.
The primary harm outcome was complications of treatment (intraoperative and postoperative), to include the incidence of grouped complications according to severity, for example, Clavien-Dindo, or incidence of ad hoc individual complications such as ureteric injury, steinstrasse (for SWL only), urosepsis, and urinoma.
Assessment of risks of bias
Risk of bias was assessed by using the recommended tool in the Cochrane Handbook for Systematic Reviews of Interventions [16] . This includes the assessment of: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. Risk of bias in nonrandomised comparative studies was assessed using all the seven domains above, with an extra item to assess the risk of findings being explained by confounding factors. This is a pragmatic approach informed by methodological literature pertaining to assessing risk of bias in nonrandomised studies [18] . A list of the most important potential confounders for harm and benefit outcomes was developed a priori with clinical content experts (the EAU Urolithiasis Guideline Panel). For each study, we asked whether each prognostic confounder was considered, whether the confounder was balanced between the intervention and control group, and whether, if necessary, the confounder was controlled for in analysis. The potential confounding factors prioritised were: stone size, body mass index (BMI) or other measure of obesity, stone composition, stone density (ie, Hounsfield units), type of lithotripsy for URS (ie, laser vs no laser for URS), sex (for children only), type of URS (ie, semirigid vs flexible), stent versus no stent prior to treatment (for both interventions), and number of SWL/URS sessions. Stone size, BMI, and stone composition were considered the most likely to influence outcomes and are reported in the risk of bias graph.
2.7.
Quality of evidence assessment
The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool [19] was used to assess the quality of evidence for URS versus SWL. Quality of evidence for critical and important outcomes for decision making were rated on study design, risk of bias, directness, consistency, and precision [19] . The SFR outcome was rated as critical for decision making. Four weeks were considered to be the most appropriate time point on which to GRADE the quality of evidence because it is a fair trade-off between an immediate SFR in the URS arms and allows for a package of care approach in the extracorporeal SWL arms. Clavien Grade !3, and need for secondary procedure were rated as important for decision-making.
Data analysis
For dichotomous benefit or harm outcomes (eg, SFR or complications), we report risk ratios and 95% confidence intervals (CIs) in forest plots but we did not meta-analyse these estimates due to heterogeneity in one or several of the following factors: the study designs, the intervention schedules and utilisations in both the experimental and control groups, and the outcome definitions and timepoints of measurement. In the results tables, we report categorical data (SFR) at available time points up to 3 mo and reported p values where available. For other categorical outcomes (eg, adverse events) we report proportions. For continuous outcomes, we report mean difference with standard deviation and/or range and corresponding 95% CIs, where available. The primary analysis was per participant randomised. For studies with more than two intervention groups, only the intervention groups relevant to the review were selected, or where possible, groups were combined to enable a single pair-wise comparison.
We conducted an intention-to-treat analysis, if data were available; otherwise an available case analysis was performed. We did not impute missing data. In the case of incompletely reported data, attempts were made to contact the relevant authors where possible.
3.
Evidence synthesis
Search results
The study selection process is outlined in the Preferred Reporting Items for Systematic Reviews and Meta-analyses [15] diagram ( Supplementary Fig. 1 ). The initial search returned 5380 abstracts of which 387 were scrutinized for eligibility. No study on children fulfilling the inclusion criteria was found. A total of 47 studies were eligible for final inclusion; 22 of these compared URS with SWL. Of these, 18 were full text articles [5, 9, 11, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] and four were conference abstracts [35] [36] [37] [38] .
Study and patient characteristics
Of the 22 final studies comparing SWL with URS, four were RCTs [11, 20, 21, 35] , one was a QRCT [22] and 17 [5, 9, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [36] [37] [38] were comparative NRSs. Of the final 25 included comparative intragroup (intra-SWL and intra-URS) studies, 24 were full text articles [7, , and one was a conference abstract [62] . There was heterogeneity in study designs and outcomes measured. Details of all studies and baseline characteristics of the participants in the included studies are outlined in Supplementary Table 1 .
Risk of bias assessment of the included studies
The risk of bias assessment for RCTs and NRSs can be viewed in Supplementary Figure 2 and Supplementary Figure 3 , respectively. In general, there was a low risk of bias for intergroup RCTs/QRCTs, low to moderate risk of bias for intragroup RCTs/QRCTs, while for both intergroup and intragroup NRSs there was a moderate to high risk of bias for included studies. As for confounding factors BMI, stone size, and stone composition the NRSs had in general high to very high risks of bias.
Comparisons of interventions results
Principal results can be viewed in Table 1 , Supplementary  Table 2 , and in the Forest plots in Figs. 1 and 2.
3.5.
Evidence synthesis for intergroup comparative studies
SFR SWL versus URS
All included studies reported SFRs; however, the time points at which these were measured were heterogeneous. ''Stonefree'' was defined for the purposes of this review as no stone fragments remaining at the reported time point. Stone-free status was measured immediately in four studies [11, 29, 31, 33] , at 1 wk in one study [20] , at 2 wk in two studies [21, 22] , at 3 wk in one study [9] , at 4 wk in four studies [24, 25, 30, 32] , at 6 wk in one study [27] , at 3 mo in six studies [5, 9, 24, 28, 30, 35] , and was unclear in six studies [23, 26, 34, [36] [37] [38] . In three of the studies two different SFR time points were measured within each study [9, 24, 30] . As summarised in Fig. 1 , achievement of stone-free status favouring URS reached statistical significance in nine studies [22, 24, 25, [29] [30] [31] [32] [33] 36] of which four were significant at 4 wk [24, 25, 30, 32] . In the remaining 13 studies [5, 9, 11, 20, 21, 23, [26] [27] [28] 34, 35, 37, 38] no significant difference was found between SWL and URS for the treatment of proximal ureteric stones. There was significant heterogeneity in the lithotripter devices used, their power settings, the modalities used for SFR assessment, and the number of shock waves delivered among those patients treated with SWL. The SFR also varied widely in the studies reporting on SWL-treated patients. The methods of anaesthesia, sizes of ureteroscopes, protocols for postoperative stenting, and method of intracorporeal lithotripsy used in the reported studies also varied. Nine of the studies provided further breakdowns of SFRs according to stone size [20, 22, [26] [27] [28] [29] 31, 33, 35] . In all but one of these studies [20] (which subdivided stones into those 12 mm and > 12 mm), this breakdown consisted of stones >10 mm and stones <10 mm. With regards to >10 mm sized stones, five studies showed SFR to be superior with URS [20, 26, 29, 31, 33] , whilst four studies [22, 27, 28, 35] showed no difference. For the smaller stones (17) 18 ( <10 mm, three studies showed SFR to be superior with URS [26, 31, 33] , whilst five studies showed no difference [22, [27] [28] [29] 35 ].
Complications
Complications of treatment were reported on in 14 out of 22 studies; two RCTs [11, 35] , one QRCT [22] , and nine NRSs [9, [23] [24] [25] [26] [28] [29] [30] [31] [32] [33] . In eight of these studies, it was possible to group the reported complications into Clavien-Dindo Grades [9,11,22,24,26,28,30,31] and grades !3 are reported in the forest plot in Fig. 2 . Lee et al [11] reported significantly higher complication rates in the URS group compared with the SWL group. The reverse finding was reported by Salem [22] and Lee et al [26] albeit in both studies the higher Clavien-Dindo Grade !3 in the SWL arms were solely due to stone migration emergency room visits with some requiring JJ stent insertion. The remaining five studies [9, 24, 28, 30, 31] failed to show any significant difference in Clavien-Dindo Grade !3 complications. No cases of ureteric injury were reported in any patients undergoing SWL, but ureteric injury rates after URS were as high as 30% in one study [11] . In other studies, reported ureteric injury rates after URS were much lower at 0-6.6% [9, 23, 25, 26, 29, 32] . Haematuria post-treatment was reported on by four studies; one RCT [11] , one QRCT [22] , and two NRSs [9, 23] . Two studies reported associated p values; in one study [9] haematuria rates (assessed according to a visual analogue score) were significantly higher after URS than SWL. In the other study [23] , rates of gross haematuria following treatment were significantly higher after SWL than URS, occurring in 20% of patients after SWL, compared with 2.5% of patients treated with URS.
The rate of steinstrasse following treatment with SWL was reported on by two studies [26, 28] ranging between 2.3% and 7.7%.
Post-treatment voiding symptoms were assessed by one study [23] and were significantly more common after treatment with URS (33.7%) compared with SWL (6.2%; p < 0.05).
Reported rates of pain were assessed by five studies [9, 11, 23, 26, 31] . Different methods and time points were used to assess the pain. In general, the reported pain levels were relatively low. Two studies reported significantly higher rates of pain after URS [11, 23] , while the three remaining studies showed no significant difference in pain after SWL or URS treatment [9, 26, 31] .
Retreatment rate
Retreatment was defined as a subsequent intervention for the stone disease using the same therapeutic technique as the initial treatment. A total of 11 studies reported on retreatment rates; three RCTs [11, 20, 35] , one QRCT [22] , and seven NRSs [5, 9, 23, 30, 33, 34, 38] . Reported retreatment rates were higher for SWL compared with URS in all studies but one [9] . Reported rates ranged from 3-61.1% for SWL compared with 0-18% for URS. Altogether, pvalues were only reported in three out of the 11 studies [5, 35, 38] of which two were statistically significant (p 0.001) [35, 38] .
Need for secondary procedures
Secondary procedures were defined as any procedure performed to clear the stone, beyond the primary procedure, including retreatment using the same modality. A total of 11 studies comparing SWL with URS reported on the need for secondary procedures; three RCTs [11, 20, 35] , one QRCT [22] , and eight NRSs [5, 26, 28, [30] [31] [32] 38] . Overall, between these 11 studies, 880 patients were treated primarily with SWL and 787 patients were treated primarily with URS. The need for secondary procedures ranged from 2.6% to 45% in the primary SWL group and 4-50% in the primary URS group. For patients treated primarily with SWL and URS, respectively, the secondary procedure modalities (eg, SWL, URS, antegrade URS, and ureterolithotomy) varied greatly between studies. In two studies [28, 38] the need for secondary procedures was equivalent between the two treatment modalities. In three studies [5, 11, 26] the need for secondary procedures was greater for URS than for SWL, although only one of these [5] provided a p-value which was not statistically significant. In the remaining six studies, the need for secondary procedures was greater for SWL than URS, although again, where given, p-values never reached statistical significance.
Need for adjunctive procedures
Adjunctive procedures were defined as procedures needed to deal with a postoperative complication of the primary treatment or temporary procedures necessary to perform the primary treatment (eg, JJ stent or nephrostomy placement). A total of seven studies reported on the need for adjunctive procedures; one RCT [11] , one QRCT [22] , and five NRSs [27] [28] [29] 31, 32] . In the majority of cases, this adjunctive procedure was the insertion of a JJ stent and was a more common occurrence when primary treatment was URS rather than SWL. Furthermore, in six of the seven studies [11, 22, [27] [28] [29] 32] , an adjunctive procedure (insertion of a JJ stent) was only required in patients who had undergone URS rather than SWL. Conversely, in one study [31] prestenting was more common in patients undergoing SWL than those undergoing URS (p < 0.01).
Duration of procedure
A total of eight studies reported on the mean duration of procedure; one RCT [11] , one QRCT [22] , and six NRSs [9, 23, 29, 30, 32, 33] . The mean duration of procedures ranged from 36 min to 61 min for SWL and 34 min to 109 min for URS. Relevant p-values were only provided in two studies [11, 23] ; in one study, the duration of procedure was significantly longer (p < 0.01) for URS than for SWL [11] but in the other study [23] there was no statistically significant difference in the duration of both procedures. Three studies [29, 31, 33] broke down the duration of procedure into two groups according to stone size of <10 mm and >10 mm. Statistical significance was not assessed by any of these studies, but raw values of mean procedural duration were greater for URS compared with SWL in one study [31] regardless of stone size, with completely the opposite findings in the second study [33] . In the third study [29] , the duration was greater for URS compared with SWL for stones >10 mm, with the reverse results for stones <10 mm.
Quality of life
Quality of life was assessed only in one study; Cui et al [23] and was not statistically significant between the two treatment modalities.
Length of hospital stay
Length of stay was reported in four studies; two RCTs [11, 21] and two NRSs [9, 28] . In all four studies, the mean length of hospital stay was greater for patients undergoing URS compared with SWL and in two of the four studies [11, 21] a p-value was provided, and in both cases, reached statistical significance.
Hospital re-admission rates and post-treatment visits
Hospital re-admission rates following treatment were assessed by one study [32] , and in this study, no patients in either treatment arm required re-admission. Two studies looked at emergency department visits after stone management [22, 32] with higher rates in those treated with SWL (20% of patients after SWL vs 5% of patients after URS). The number of post-treatment visits was assessed by two studies [21, 31] . In the Zhang et al study [21] , the number of post-treatment visits was not significantly different between the two treatment groups, whereas in the Parker et al study [31] , patients were seen significantly more often following treatment with SWL than after URS; 2.4 AE 1.2 compared with 1.4 AE 0.8 (p 0.0001).
Cost analysis
Only three studies looked at cost analysis. According to Zhang et al [21] , URS was significantly more expensive than SWL, whereas Parker et al [31] and Wu et al [29] reported significant higher costs for SWL (p < 0.01 in both studies).
Quality of evidence assessment
The GRADE quality of evidence for URS versus extracorporeal SWL is shown in the evidence profile (Supplementary Table 3 ). The overall quality of evidence for SFR at 4 wk, !Grade 3 Clavien-Dindo complications and the need for secondary procedures were all very low. This indicates that we are very uncertain about the estimate. The main reasons were the impact of confounding bias in the observational studies, as well as small study populations throughout. Furthermore, the complications and secondary procedures outcomes had low event rates, heterogeneous estimates of effect, and wide CIs.
3.16.
Evidence synthesis for intragroup (intra-SWL and intra-URS) comparative studies
Immediate SWL versus delayed SWL
Three studies compared outcomes from immediate SWL versus those with delayed SWL [39] [40] [41] . All three studies showed higher SGRs when SWL was administered immediately (within 2 d) rather than if treatment was delayed (range, ! 2-7 d) from time of symptom. The difference was statistically significant in two of the three studies [39, 41] . One study showed that the mean number of SWL sessions was higher in patients undergoing delayed SWL compared with immediate SWL, with a reported p-value of 0.047 provided by one study [41] . One study compared SFR using SWL for urinary stones 1 cm compared to SWL for stones >1 cm in diameter [54] . Subgroup analysis of upper urinary system (UUS) showed a SFR of 60.8% for stones 1 cm compared to 49.1% for stones >1 cm albeit not significant (p = 0.496).
SWL with medical expulsion therapy [44] versus SWL alone
Four studies compared the effect of an alpha-blocker on stone free rates with SWL treatment [42] [43] [44] 62] . SFRs were better with concomitant alpha-blocker use in all four studies; two of which provided statistically significant p values [42, 43] . One study [45] looked at the effect of a calcium-channel blocker on SFRs with SWL treatment where SFRs were improved with nifedipine administration (75% compared with 44%, but no p value provided). Mean analgesic use (diclofenac) was also reduced in patients receiving nifedipine (p = 0.02). While one study showed number of SWL sessions needed was not significantly changed by alpha-blocker administration [43] , another study showed that patients receiving tamsulosin required significantly less number of SWL sessions (p = 0.02) [42] .
SWL with diuresis versus SWL alone
Two studies looked at the effect of diuretic treatment alongside treatment with SWL [46, 47] . Although SFRs were equivalent in one study [47] , improved SFRs at 3 mo were observed when furosemide was administered alongside SWL therapy in another study [46] (86.6% vs 58.8%). However, p values were not provided in either study.
SWL in patients with hydronephrosis versus SWL in patients without hydronephrosis
Two studies looked at the effect of SWL on patients with and without hydronephrosis due to UUS [7, 48] . There was no significant difference found in SFR at 3 mo between these two groups in neither study, although one [7] showed a significant (p < 0.01) longer time to complete stone clearance in patients with hydronephrosis.
SWL prone versus SWL supine
Two studies addressed the effect of patient positioning on treatment outcomes with SWL [49, 50] . In one study, there was no significant difference in the achieved SFR at 2 wk [50] , whereas in the other study, these rates were improved by treating the patient prone rather than supine (90.6% vs 88.3%, p < 0.05) [49] .
SWL 60-80 s/min versus SWL 120 s/min
Three studies looked at whether the administered shock rate affected SFRs [51, 53, 56] . In all studies, SFRs were higher when shock waves were administered at a slower rate, reaching a statistically significant difference (p < 0.05) in one study [53] . One study showed that the mean number of SWL sessions required was reduced in patients undergoing fast SWL (p = 0.021) [51] . The other study showed that duration of procedure was significantly reduced in patients undergoing fast SWL compared to slow SWL (p < 0.001) [53] . A similar result was reported in one study [56] but no p-value was reported.
SWL with and without stenting
One study looked at the effect of prestenting on SFRs with SWL [52] . In this study, high SFRs were seen in both treatment groups; 86.7% in the nonstented group and 90% in the stented group, and there was no statistically significant difference in the achieved SFRs.
SWL under sedation versus under general anaesthesia
One study looked at SFRs in patients undergoing SWL under sedation, versus under general anaesthesia [59] . Stone-free rates at 3 mo were higher in those treated under a general anaesthesia (80% compared with 50%), but no p value was given.
SWL using different lithotriptors
Three studies examined different types of SWL lithotriptors for UUS [55, 57, 58] . The first study [55] showed no difference (88% vs 92%, p = 0.245) in SFR between electrohydraulic (EH) and electromagnetic lithotriptors in treating UUS. The second study [57] compared an EH, electromagnetic, and a piezoelectric lithotripter to each other in treating urinary stones. The EH lithotriptor was suggested in a multivariate analysis to have a better SFR and lower retreatment rate, although p-values for UUS were not provided. Finally, a third study [58] compared an EH model (HM3) to a more modern EH (LithoTron) model lithotripter in a small matched pair analysis. No significant differences were found (p = 0.08).
URS with and without methods for preventing retrograde stone migration
Two studies looked at stone-free rates with ureteroscopic treatment using different methods for preventing retrograde stone migration during the procedure. The first, a RCT, looked at URS with and without a backstop device [60] . SFRs were high in both groups (93.9% with backstop device compared to 87.8% without, p-value = 0.7). The second, a QRCT, looked at URS with and without lubrication jelly instilled proximal of the stone [61] . SFRs were high in both groups (93.7% with jelly compared with 83.3% without, p = 0.384).
Discussion
Implications for clinical practice
Our systematic review demonstrates that URS and SWL are both safe and effective in the treatment of proximal ureteric stones.
The key observation of this study, that short-term SFR are better with URS compared with SWL, is perhaps unsurprising given the advantages of direct stone visualisation that this technique confers, enabling more accurate delivery of the chosen stone fragmentation modality onto the stone, combined with the ability to actively retrieve stones and/or fragments using baskets and forceps after stone fragmentation. Historically, the success rates associated with ureteroscopic treatment of proximal ureteral stones were suboptimal compared with the results of other treatment modalities. In general, the low success rates were attributable to the inability to reach the stone, inability to fragment the stone, or cephalad stone migration during treatment. Technological advances such as introduction and downsizing of the flexible ureteroscopes and the development of Ho:YAG laser have greatly improved interest and efficacy of ureteroscopy for proximal ureteral stone treatment. The advent of new technology is inevitably correlated with changes in the treatment of proximal ureteral stones as suggested in International Urological Guidelines over the last 20 yr. In the 1990s, the recommended first-line therapy for stones with a diameter <1.0 cm in the proximal ureter was SWL. Ureteroscopy or more invasive PCNL was recommended for salvage treatment or if SWL was contraindicated. For stones >1 cm in the proximal ureter, SWL, URS, or PCNL was recommended as first-line treatment [63] . The 2007 EAU/American Urological Association Guidelines for the management of ureteral calculi indicated that besides SWL, URS should be considered for stones 10 mm located in the proximal ureter. When stones of this diameter were stratified by stone location, median SFR remained superior for URS over SWL at all locations. In regards to 10mm proximal ureteral stones, SFR for URS reached 85% compared with 66.5% for SWL. However, for stones >10 mm, SFR were comparable for URS and SWL (74% vs 79%) in the proximal ureter [64] . The current, 2016 American Urological Association Guidelines state that URS for proximal ureteral stones has a greater SFR in a single procedure compared with SWL, regardless of stone size [65, 66] , albeit the importance of informing patients on the higher morbidity and complications risk compared with SWL. All in all, URS can be recommended as the first treatment option for proximal ureteral stones >10 mm, but for stones 10 mm the EAU Urolithiasis Guidelines panel consensus is that either treatment options are viable as first choice and should be presented to patients [67] . The effectiveness of medical expulsive therapy, in particular ablockers, as conservative treatment of ureteral stones is unproven and the only potential benefit seems to exist for distal ureteral stones larger than 5 mm [68] .
Counterbalancing for URS's higher SFRs, SWL is associated with the least morbidity and lower complication rates [65] [66] [67] . In this current systematic review, Clavien-Dindo grade complications were, if reported, less frequent in patients treated with SWL. At the same time, two studies [22, 26] presented the opposite, pointing out that stone migration/steinstrasse requiring decompression with JJ stent insertion (ie, making it a Clavien-Dindo Grade 3 complication) is more frequent in patients treated with SWL. However, it is important to bear in mind that the quality of evidence is very low. The 2012 Cochrane metaanalysis comparing SWL and URS identified seven randomised controlled studies reporting on all complication rates and found a significantly lower complication rate for SWL compared with URS (risk ratio: 0.53, 95% CI: 0.33-0.88, p = 0.01) [69] . However, for all patients with ureteral stones, when residual fragments are present, especially if initial SWL fails, urologists should offer endoscopic procedures to render the patients stone free. Success rates for PCNL and URS as secondary procedures after failed SWL are reported as 86-100% and 62-100%, respectively [65, 66] .
Our intragroup comparative studies analysis underlined several technical modifications leading to higher SWL SFR. Despite this improvement, the aforementioned international recommendations clearly reflect a trend towards URS as treatment of proximal ureteral stones regardless of the size of the stone. However, it is difficult to make a blanket recommendation as to whether all ureteroscopic stone treatment techniques are better than all SWL machine types and treatment schedules, for treating all proximal ureteric stones, regardless of stone size and other important patientrelated factors such as BMI; these variables as well as other confounding factors simply have not been adequately reported on in the currently available studies and future research should definitely focus on these. Moreover, other factors such as technological improvements (eg, Ho:YAG laser, uretererosope miniaturisation), country policies, capital investment, and the patient's or surgeon's preference could affect the results of URS and SWL.
As techniques, technologies, and surgeon experience continue to evolve, further large, multi-centre, welldesigned RCTs are needed in order to accurately compare these two treatment modalities. Further research is also needed to overcome several of the limitations of this study. For example, many of the included studies may be affected by selection bias, performance bias, detection bias, and outcome-reporting bias. Moreover, despite the moderate statistical heterogeneity of our review, clinical heterogeneity can be expected, by including trials using different type of lithotripters/methods of lithotripsy, different follow-up periods defining SFR, differences in stone size and imaging, as well as different adjunctive procedures. Furthermore, for five of the included studies, only abstracts were available for data extraction, which significantly limited the information and quality of data available for analysis. Even when full texts were available, there was a lack of adequate and reliable evidence for the comparison of URS versus SWL concerning outcomes other than SFR and where it was possible to extract data on the main outcome measures of this study, many studies did not report statistical calculations of differences between the two interventional groups. Moreover, available data reported in the literature was not strong enough to report some certain patient-focused outcomes, for example, analgesic requirement, emergency department visits, and quality of life, and cost analysis outcomes were poor. Where patient-focused outcomes were assessed, for example, lower urinary tract symptoms or quality of life following treatment [33] , validated questionnaires were not used.
We assert that increasing the number of well-designed RCTs focusing mainly on these parameters will ease the clinician's and also patient's decision making. In order to decrease heterogeneity in future studies, consensus is needed regarding the definition and timing of stone free, including the imaging modality used for assessing SFR. Moreover, a core outcome set is needed to ensure that the outcomes, which are of utmost importance for decision making for all stakeholders including patients, are reported, defined, and measured consistently [70] [71] [72] . This will ensure that future trials are efficient and future evidence syntheses are straightforward to perform, communicate, and are ultimately useful for decision making by patients, clinicians, and health care policy makers and funders.
Conclusions
This systematic review demonstrates that ureteroscopic management of proximal ureteral calculi is associated with a significantly greater SFR when compared with SWL at 1 mo. Moreover, the rate of retreatment and the need for secondary procedures was found to be higher in cases undergoing SWL. Concerning adjunctive procedures, complications, and length of hospital stay; however, the ureteroscopic approach was found to be associated with higher complication rates along with longer hospitalisation periods when compared with SWL. However, the quality of evidence is very low and it is therefore clear that in order to better outline the efficacy, complications, and other treatment-related parameters of both modalities, further well-designed RCTs with larger sample sizes and consistently reported and defined outcomes are needed.
